Theodore S. Lawrence

43.0k total citations · 7 hit papers
622 papers, 28.0k citations indexed

About

Theodore S. Lawrence is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Theodore S. Lawrence has authored 622 papers receiving a total of 28.0k indexed citations (citations by other indexed papers that have themselves been cited), including 224 papers in Radiology, Nuclear Medicine and Imaging, 201 papers in Oncology and 182 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Theodore S. Lawrence's work include Advanced Radiotherapy Techniques (114 papers), Hepatocellular Carcinoma Treatment and Prognosis (109 papers) and Glioma Diagnosis and Treatment (70 papers). Theodore S. Lawrence is often cited by papers focused on Advanced Radiotherapy Techniques (114 papers), Hepatocellular Carcinoma Treatment and Prognosis (109 papers) and Glioma Diagnosis and Treatment (70 papers). Theodore S. Lawrence collaborates with scholars based in United States, China and Canada. Theodore S. Lawrence's co-authors include Randall K. Ten Haken, Meredith A. Morgan, Daniel P. Normolle, Donna S. Shewach, Cornelius J. McGinn, James M. Balter, Mary A. Davis, Jonathan Maybaum, Laura A. Dawson and Alnawaz Rehemtulla and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Theodore S. Lawrence

602 papers receiving 27.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Analysis of radiation-induced liver disease using the Lyman NTCP model

2002 581 citations Daniel P. Normolle, Theodore S. Lawrence et al. profile →
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells

2009 558 citations Qing Ji, Xinbao Hao et al. profile →
Hepatic toxicity resulting from cancer treatment

1995 522 citations Theodore S. Lawrence et al. profile →
Functional diffusion map: A noninvasive MRI biomarker for early stratification of clinical brain tumor response

2005 489 citations Thomas L. Chenevert, Theodore S. Lawrence et al. profile →
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression

2018 449 citations Shuang Wei, Michael D. Green et al. profile →
Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma

2015 379 citations Daniel Wahl, Theodore S. Lawrence et al. Journal of Clinical Oncology profile →
Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non–Small-Cell Lung Cancer

2017 259 citations M.M. Matuszak, Randall K. Ten Haken et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Theodore S. Lawrence

Since Specialization

Citations

This map shows the geographic impact of Theodore S. Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theodore S. Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theodore S. Lawrence more than expected).

Fields of papers citing papers by Theodore S. Lawrence

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Theodore S. Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theodore S. Lawrence. The network helps show where Theodore S. Lawrence may publish in the future.

Co-authorship network of co-authors of Theodore S. Lawrence

This figure shows the co-authorship network connecting the top 25 collaborators of Theodore S. Lawrence. A scholar is included among the top collaborators of Theodore S. Lawrence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Theodore S. Lawrence. Theodore S. Lawrence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predictors of Acute and Late Toxicity in Patients Receiving Chemoradiation for Unresectable Pancreatic Cancer 2023 ·Advances in Radiation Oncology ·(unknown), (unknown), Scott Hadley, Vaibhav Sahai, Filip Bednar, Joseph R. Evans, Matthew J. Schipper, Theodore S. Lawrence, Kyle C. Cuneo	4
2	A clinical decision support system for AI-assisted decision-making in response-adaptive radiotherapy (ARCliDS) 2023 ·Scientific Reports ·Dipesh Niraula, (unknown), Jionghua Jin, Ivo D. Dinov, Kyle C. Cuneo, (unknown), M.M. Matuszak, Yi Luo, Theodore S. Lawrence, Shruti Jolly, Randall K. Ten Haken, Issam El Naqa	27
3	Combinatorial Efficacy of Olaparib with Radiation and ATR Inhibitor Requires PARP1 Protein in Homologous Recombination–Proficient Pancreatic Cancer 2020 ·Molecular Cancer Therapeutics ·Leslie A. Parsels, Carl G. Engelke, Joshua D. Parsels, (unknown), Qiang Zhang, Daria M. Tanska, Daniel Wahl, Christine E. Canman, Theodore S. Lawrence, Meredith A. Morgan	29
4	Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy 2019 ·Cancer Research ·Qiang Zhang, Michael D. Green, Xueting Lang, Jenny Lazarus, Joshua D. Parsels, Shuang Wei, Leslie A. Parsels, Jiaqi Shi, Nithya Ramnath, Daniel Wahl, Marina Pasca di Magliano, Timothy L. Frankel, Ilona Kryczek, Yu L. Lei, Theodore S. Lawrence, Weiping Zou, Meredith A. Morgan	150
5	Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis 2016 ·Cancer Research ·Daniel Wahl, Joseph Dresser, Kari Wilder-Romans, Joshua D. Parsels, Shuang G. Zhao, Mary A. Davis, Lili Zhao, Maureen Kachman, Stefanie Wernisch, Charles Burant, Meredith A. Morgan, Felix Y. Feng, Corey Speers, Costas A. Lyssiotis, Theodore S. Lawrence	67
6	HAb18G/CD147 Promotes pSTAT3-Mediated Pancreatic Cancer Development via CD44s 2013 ·Clinical Cancer Research ·Ling Li, Wenhua Tang, Xiaoqing Wu, David Karnak, Xiaojie Meng, R. Thompson, Xinbao Hao, Yongmin Li, Xiaotan T. Qiao, Jiayuh Lin, James R. Fuchs, Diane M. Simeone, Zhi‐Nan Chen, Theodore S. Lawrence, Liang Xu	57
7	Inhibition of Protein Phosphatase 2A Radiosensitizes Pancreatic Cancers by Modulating CDC25C/CDK1 and Homologous Recombination Repair 2013 ·Clinical Cancer Research ·Dongping Wei, Leslie A. Parsels, David Karnak, Mary A. Davis, Joshua D. Parsels, (unknown), Lili Zhao, Jonathan Maybaum, Theodore S. Lawrence, Yi Sun, Meredith A. Morgan	80
8	Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776 2013 ·Clinical Cancer Research ·Carl G. Engelke, Leslie A. Parsels, Yushen Qian, Qiang Zhang, David Karnak, (unknown), Daria M. Tanska, Dongping Wei, Mary A. Davis, Joshua D. Parsels, Lili Zhao, Joel K. Greenson, Theodore S. Lawrence, Jonathan Maybaum, Meredith A. Morgan	89
9	Radiosensitization of Head and Neck Squamous Cell Carcinoma by a SMAC-Mimetic Compound, SM-164, Requires Activation of Caspases 2011 ·Molecular Cancer Therapeutics ·Jie Yang, Donna McEachern, Wenyan Li, Mary A. Davis, Hua Li, Meredith A. Morgan, Longchuan Bai, (unknown), Haiying Sun, Theodore S. Lawrence, Shaomeng Wang, Yi Sun	43
10	Radiosensitization of Human Pancreatic Cancer Cells by MLN4924, an Investigational NEDD8-Activating Enzyme Inhibitor 2011 ·Cancer Research ·Dongping Wei, Hua Li, Jie Yu, (unknown), Lili Zhao, Theodore S. Lawrence, Peter G. Smith, Meredith A. Morgan, Yi Sun	136
11	Bayesian Hierarchical Changepoint Methods in Modeling the Tumor Growth Profiles in Xenograft Experiments 2010 ·Clinical Cancer Research ·Lili Zhao, Meredith A. Morgan, Leslie A. Parsels, Jonathan Maybaum, Theodore S. Lawrence, Daniel P. Normolle	26
12	Role of Epidermal Growth Factor Receptor Degradation in Cisplatin-Induced Cytotoxicity in Head and Neck Cancer 2010 ·Cancer Research ·Aarif Ahsan, Susan M. Hiniker, Susmita G. Ramanand, Shyam Nyati, Ashok N. Hegde, (unknown), (unknown), Mahaveer S. Bhojani, Theodore S. Lawrence, Mukesh K. Nyati	57
13	Mechanism of Radiosensitization by the Chk1/2 Inhibitor AZD7762 Involves Abrogation of the G2 Checkpoint and Inhibition of Homologous Recombinational DNA Repair 2010 ·Cancer Research ·Meredith A. Morgan, Leslie A. Parsels, Lili Zhao, Joshua D. Parsels, Mary A. Davis, Maria Hassan, Sankari Arumugarajah, Linda Hylander-Gans, Deborah Morosini, Diane M. Simeone, Christine E. Canman, Daniel P. Normolle, Sonya Zabludoff, Jonathan Maybaum, Theodore S. Lawrence	249
14	Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells 2009 ·Molecular Cancer Therapeutics ·Leslie A. Parsels, Meredith A. Morgan, Daria M. Tanska, Joshua D. Parsels, Brian D. Palmer, R J Booth, William A. Denny, Christine E. Canman, Alan J. Kraker, Theodore S. Lawrence, Jonathan Maybaum	120
15	Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa 2008 ·Molecular Cancer Therapeutics ·Yang Meng, Wenhua Tang, Yao Dai, Xiaoqing Wu, Meilan Liu, Qing Ji, Min Ji, Kenneth J. Pienta, Theodore S. Lawrence, Liang Xu	167
16	Functional Diffusion Map As an Early Imaging Biomarker for High-Grade Glioma: Correlation With Conventional Radiologic Response and Overall Survival 2008 ·Journal of Clinical Oncology ·Daniel A. Hamstra, Craig J. Galbán, Charles R. Meyer, Timothy D. Johnson, Pia C. Sundgren, Christina Tsien, Theodore S. Lawrence, Larry Junck, David J. Ross, Alnawaz Rehemtulla, Brian D. Ross, Thomas L. Chenevert	214
17	Effect of Epidermal Growth Factor Receptor Inhibitor Class in the Treatment of Head and Neck Cancer with Concurrent Radiochemotherapy In vivo 2007 ·Clinical Cancer Research ·Felix Y. Feng, Carlos López, Daniel P. Normolle, Sooryanarayana Varambally, (unknown), Patrick Chun, Mary A. Davis, Theodore S. Lawrence, Mukesh K. Nyati	41
18	Inhibition of Protein Kinase Cβ by Enzastaurin Enhances Radiation Cytotoxicity in Pancreatic Cancer 2007 ·Clinical Cancer Research ·Aaron C. Spalding, Richard Watson, Mary E. Davis, Alex C. Kim, Theodore S. Lawrence, Edgar Ben‐Josef	19
19	Ataxia Telangiectasia Mutated Down-regulates Phospho-Extracellular Signal-Regulated Kinase 1/2 via Activation of MKP-1 in Response to Radiation 2006 ·Cancer Research ·Mukesh K. Nyati, Felix Y. Feng, (unknown), Sooryanarayana Varambally, Steven P. Zielske, Aarif Ahsan, Patrick Chun, Vinay A. Arora, Mary A. Davis, Mira Jung, Mats Ljungman, Christine E. Canman, Arul M. Chinnaiyan, Theodore S. Lawrence	25
20	Synergistic Effects of Gemcitabine and Gefitinib in the Treatment of Head and Neck Carcinoma 2006 ·Cancer Research ·Patrick Chun, Felix Y. Feng, (unknown), Mary A. Davis, Theodore S. Lawrence, Mukesh K. Nyati	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact